CAD/MI Flashcards
Omega 3 1g/d
Benefits in reducing CV events in EF
STE definition
> /=2 contiguous leads with >/=1 mm except v2-v3: >/=2mm in men, >/=1.5 in women
New LBBB
PCI time
90 min
Fibrinolytic therapy time
30 min
Indication for primary PCI
STE and symptoms
Indication of fibrinolytic
STE/LBBB with symptoms
iCH in fibrinolysis
2% in >75 yo
Contraindications to fibrinolysis
Hx ICH
Intracranial neoplasm, aneurysm, AVM
Within last 3mon, no hemorrhagic stroke, or closed head trauma
Active bleeding or known bleeding diathesis
Suspected aortic dissection
gP 2b/3a
No role in lysis
Peri PCI decrease death, MI
uFH
No mortality benefit
Increase patency with lyrics
Beta blockers in MI immediately
Decrease arrhythmic death or reMI, increase cardio genie shock,
NO overall mortality change when given early, esp if HF
Inotropes in HF
Use inotropes if HF despite diuresis, and decrease after load, use dopamine, dobutamine or milrinone
RV infarct
1mm STE in V4R, RA/PCWP>/=0.8
Optimize preload RA goal 10-14
Increase contractility dobutamine
Post MI mechanical complications
Free wall rupture
vSD: aMI, IMI
Papillary muscle rupture: IMI
Predictor of mi mortality
Age, time to rx, anterior MI or LBBB, heart failure
Beta blockers after MI long term therapy
23% reduction in mortality
ACEI in MI
Life long if HF, decreased EF, HTN, DM
4-6 weeks in all STEMI
Aldosterone antagonist
15% reduction in mortality if EF
iCD indications post MI
Sustained VT/VF >2d post MI not due to reversible ischemia
Indicated in primary prevention of SCD if post MI with EF
Posterior infarct
V1-V2 with ST depressions. to request posterior (V7-V9) leads to check for posterior MI. Posterior infarct can be associated with inferior infarcts (90%) and lateral infarcts (10%) as the posterior descending artery may be supplied by RCA or left circumflex coronary artery.
Tall R waves in V1 (R/S >1)
RBBB, RVH, left ventricular ectopy, acute right ventricular dilation (acute right heart strain), type A Wolff-Parkinson-White syndrome, posterior myocardial infarction, hypertrophic cardiomyopathy, progressive muscular dystrophy, dextrocardia, misplaced precordial leads, and normal variant (